Targeting the Peroxisome Proliferator-Activated Receptor-gamma to Counter the Inflammatory Milieu in Obesity

被引:13
|
作者
Corzo, Cesar [1 ]
Griffin, Patrick R. [1 ]
机构
[1] Scripps Res Inst, Dept Mol Therapeut, 130 Scripps Way 2A2, Jupiter, FL 33458 USA
关键词
Diabetes; Hypoglycemic agents; Metabolic disorders; Metabolic syndrome; PPAR gamma; Protein processing; post-translational; Receptors; cytoplasmic and nuclear; Review; Synthetic ligands; Thiazolidinediones;
D O I
10.4093/dmj.2013.37.6.395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adipose tissue, which was once viewed as a simple organ for storage of triglycerides, is now considered an important endocrine organ. Abnormal adipose tissue mass is associated with defects in endocrine and metabolic functions which are the underlying causes of the metabolic syndrome. Many adipokines, hormones secreted by adipose tissue, regulate cells from the immune system. Interestingly, most of these adipokines are proinflammatory mediators, which increase dramatically in the obese state and are believed to be involved in the pathogenesis of insulin resistance. Drugs that target peroxisome proliferator- activated receptor-. have been shown to possess anti- inflammatory effects in animal models of diabetes. These findings, and the link between inflammation and the metabolic syndrome, will be reviewed here.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor-gamma ligands: Thiazolidinediones
    Zingarelli, B
    SHOCK, 2004, 21 : 126 - 126
  • [2] Role of Peroxisome Proliferator-Activated Receptor-gamma in Vascular Inflammation
    Ohshima, Kousei
    Mogi, Masaki
    Horiuchi, Andmasatsugu
    INTERNATIONAL JOURNAL OF VASCULAR MEDICINE, 2012, 2012
  • [3] Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes:: a polygenic approach to obesity
    Saez, Maria E.
    Grilo, Antonio
    Moron, Francisco J.
    Manzano, Luis
    Martinez-Larrad, Maria T.
    Gonzalez-Perez, Antonio
    Serrano-Hernando, Javier
    Ruiz, Agustin
    Ramirez-Lorca, Reposo
    Serrano-Rios, Manuel
    CARDIOVASCULAR DIABETOLOGY, 2008, 7 (1)
  • [4] Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity
    María E Sáez
    Antonio Grilo
    Francisco J Morón
    Luis Manzano
    María T Martínez-Larrad
    Antonio González-Pérez
    Javier Serrano-Hernando
    Agustín Ruiz
    Reposo Ramírez-Lorca
    Manuel Serrano-Ríos
    Cardiovascular Diabetology, 7
  • [5] STRUCTURE, FUNCTION AND ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA - PPARγ
    Mrowka, Piotr
    Glodkowska-Mrowka, Eliza
    POSTEPY BIOLOGII KOMORKI, 2011, 38 (04) : 629 - 651
  • [6] Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage
    Toth, Bettina
    Bastug, Mehmet
    Mylonas, Ioannis
    Scholz, Christoph
    Makovitzky, Josef
    Kunze, Susanne
    Thaler, Christian
    Friese, Klaus
    Jeschke, Udo
    ACTA HISTOCHEMICA, 2009, 111 (04) : 373 - 379
  • [7] Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
    Hsu, Hui-Tzu
    Chi, Chin-Wen
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2014, 1 : 127 - 134
  • [9] Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
    Akihiko Takeuchi
    Norio Yamamoto
    Toshiharu Shirai
    Katsuhiro Hayashi
    Shinji Miwa
    Seiichi Munesue
    Yasuhiko Yamamoto
    Hiroyuki Tsuchiya
    BMC Cancer, 16
  • [10] Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation via Targeting NGBR Expression
    Ma, Jialing
    Zeng, Peng
    Liu, Lipei
    Zhu, Mengmeng
    Zheng, Juan
    Wang, Chengyi
    Zhao, Xiaokang
    Hu, Wenquan
    Yang, Xiaoxiao
    Duan, Yajun
    Han, Jihong
    Miao, Qing R.
    Chen, Yuanli
    FRONTIERS IN PHARMACOLOGY, 2022, 12